UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 29, 2021 4:00 P.M.
Form:
S-3
CIK:
0001701108
Company Name:
Spero Therapeutics, Inc.
File Number:
333-254170